News
A promising new cancer technology from NIH could help improve how liver cancer is diagnosed and treated. Liver cancer, particularly hepatocellular carcinoma (HCC), remains one of the deadliest cancers worldwide, and better treatment options are urgently needed. NIH inventors have developed two fully
Inventors at the National Cancer Institute’s Laboratory of Molecular Biology have isolated three anti Programed Death-Ligand 1 (PD-L1) single domain antibodies that can be used as a therapeutic for treating solid tumors. An imbalance of PD-L1 contributes to cancer immune escape and it has been
Technology Transfer Central has selected Joseph M. Conrad, Ph.D. from the National Cancer Institute’s Invention Development and Marketing Unit (IDMU) to present a webinar focused on strategies to revitalize and expand a high-touch, low-tech approach to marketing technologies. This webinar will
NIH inventor Carolina Barillas-Mury, M.D., Ph.D., has been elected into the National Academy of Medicine (NAM) this year. The NAM is made up of over 2,000 elected members from around the globe who give scientific and policy guidance relating to human health. This honor is one of the highest that can